Newman LA - Search Results

1

Determinants of breast conservation rates: reasons for mastectomy at a comprehensive cancer center.

Lee MC, Rogers K, Griffith K, Diehl KA, Breslin TM, Cimmino VM, Chang AE, Newman LA, Sabel MS. Lee MC, et al. Among authors: newman la. Breast J. 2009 Jan-Feb;15(1):34-40. doi: 10.1111/j.1524-4741.2008.00668.x. Breast J. 2009. PMID: 19141132 Free article.

2

Presentation, treatment, and outcome of local recurrence afterskin-sparing mastectomy and immediate breast reconstruction.

Newman LA, Kuerer HM, Hunt KK, Kroll SS, Ames FC, Ross MI, Feig BW, Singletary SE. Newman LA, et al. Ann Surg Oncol. 1998 Oct-Nov;5(7):620-6. doi: 10.1007/BF02303832. Ann Surg Oncol. 1998. PMID: 9831111

3

Residual metastatic axillary lymph nodes following neoadjuvant chemotherapy predict disease-free survival in patients with locally advanced breast cancer.

Kuerer HM, Newman LA, Buzdar AU, Hunt KK, Dhingra K, Buchholz TA, Binkley SM, Ames FC, Feig BW, Ross MI, Hortobagyi GN, Singletary SE. Kuerer HM, et al. Among authors: newman la. Am J Surg. 1998 Dec;176(6):502-9. doi: 10.1016/s0002-9610(98)00253-0. Am J Surg. 1998. PMID: 9926779 Clinical Trial.

4

Local recurrence and survival among black women with early-stage breast cancer treated with breast-conservation therapy or mastectomy.

Newman LA, Kuerer HM, Hunt KK, Singh G, Ames FC, Feig BW, Ross MI, Taylor S, Singletary SE. Newman LA, et al. Ann Surg Oncol. 1999 Apr-May;6(3):241-8. doi: 10.1007/s10434-999-0241-y. Ann Surg Oncol. 1999. PMID: 10340882 Clinical Trial.

5

Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy.

Kuerer HM, Sahin AA, Hunt KK, Newman LA, Breslin TM, Ames FC, Ross MI, Buzdar AU, Hortobagyi GN, Singletary SE. Kuerer HM, et al. Among authors: newman la. Ann Surg. 1999 Jul;230(1):72-8. doi: 10.1097/00000658-199907000-00011. Ann Surg. 1999. PMID: 10400039 Free PMC article. Clinical Trial.

6

Special considerations in breast cancer risk and survival.

Newman LA, Kuerer HM, Harper T, Hunt KK, Laronga C, Breslin T, Singletary SE. Newman LA, et al. J Surg Oncol. 1999 Aug;71(4):250-60. doi: 10.1002/(sici)1096-9098(199908)71:4<250::aid-jso11>3.0.co;2-3. J Surg Oncol. 1999. PMID: 10440767 Review.

7

Feasibility of immediate breast reconstruction for locally advanced breast cancer.

Newman LA, Kuerer HM, Hunt KK, Ames FC, Ross MI, Theriault R, Fry N, Kroll SS, Robb GL, Singletary SE. Newman LA, et al. Ann Surg Oncol. 1999 Oct-Nov;6(7):671-5. doi: 10.1007/s10434-999-0671-6. Ann Surg Oncol. 1999. PMID: 10560853

8

Prophylactic mastectomy.

Newman LA, Kuerer HM, Hung KK, Vlastos G, Ames FC, Ross MI, Singletary SE. Newman LA, et al. J Am Coll Surg. 2000 Sep;191(3):322-30. doi: 10.1016/s1072-7515(00)00361-6. J Am Coll Surg. 2000. PMID: 10989906 Review.

9

Impact of multicentricity on clinical outcome in patients with T1-2, N0-1, M0 breast cancer.

Vlastos G, Rubio IT, Mirza NQ, Newman LA, Aurora R, Alderfer J, Buzdar AU, Singletary SE. Vlastos G, et al. Among authors: newman la. Ann Surg Oncol. 2000 Sep;7(8):581-7. doi: 10.1007/BF02725337. Ann Surg Oncol. 2000. PMID: 11005556

10

Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancer.

Breslin TM, Cohen L, Sahin A, Fleming JB, Kuerer HM, Newman LA, Delpassand ES, House R, Ames FC, Feig BW, Ross MI, Singletary SE, Buzdar AU, Hortobagyi GN, Hunt KK. Breslin TM, et al. Among authors: newman la. J Clin Oncol. 2000 Oct 15;18(20):3480-6. doi: 10.1200/JCO.2000.18.20.3480. J Clin Oncol. 2000. PMID: 11032588 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

311 results

Search Page